Callahan, M. K., Postow, M. A. & Wolchok, J. D. Targeting T cell co-receptors for cancer therapy. Immunity 44, 1069–1078 (2016).
Article CAS PubMed Google Scholar
Attanasio, J. & Wherry, E. J. Costimulatory and coinhibitory receptor pathways in infectious disease. Immunity 44, 1052–1068 (2016).
Article CAS PubMed PubMed Central Google Scholar
Chen, L. et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093–1102 (1992).
Article CAS PubMed Google Scholar
Townsend, S. E. & Allison, J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259, 368–370 (1993). Together with Chen et al. (1992), this important study shows that co-stimulation through CD28 can induce antitumour immunity.
Article CAS PubMed Google Scholar
Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).
Article CAS PubMed Google Scholar
Kamphorst, A. O. et al. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355, 1423–1427 (2017).
Article CAS PubMed PubMed Central Google Scholar
Hui, E. et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355, 1428–1433 (2017). Together with Kamphorst et al. (2017), this paper shows that CD28 is the main target of PD1 inhibition, which led to the re-emergence of CD28 as a therapeutic target in cancer.
Article CAS PubMed PubMed Central Google Scholar
Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018–1028 (2006). This paper reports the failed phase I clinical trial of a CD28-superagonist antibody (TGN1412), which set back research into CD28 agonism for cancer therapy.
Article CAS PubMed Google Scholar
Hunig, T. The storm has cleared: lessons from the CD28 superagonist TGN1412 trial. Nat. Rev. Immunol. 12, 317–318 (2012). This paper provides a comprehensive description of lessons learned from the TGN1412 clinical trial that provides a basis for changes made to the way in which immunotherapies are clinically tested.
Horvath, C. et al. Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial. Nat. Rev. Immunol. 12, 740 (2012).
Burke, K. P., Chaudhri, A., Freeman, G. J. & Sharpe, A. H. The B7:CD28 family and friends: unraveling coinhibitory interactions. Immunity 57, 223–244 (2024).
Article CAS PubMed Google Scholar
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A. & Bluestone, J. A. CD28 costimulation: from mechanism to therapy. Immunity 44, 973–988 (2016).
Article CAS PubMed PubMed Central Google Scholar
Edner, N. M., Carlesso, G., Rush, J. S. & Walker, L. S. K. Targeting co-stimulatory molecules in autoimmune disease. Nat. Rev. Drug Discov. 19, 860–883 (2020).
Article CAS PubMed Google Scholar
Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975).
Article CAS PubMed Google Scholar
Hansen, J. A., Martin, P. J. & Nowinski, R. C. Monoclonal antibodies identifying a novel T-Cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10, 247–260 (1980).
Clark, E. A., Martin, P. J., Hansen, J. A. & Ledbetter, J. A. Evolution of epitopes on human and nonhuman primate lymphocyte cell surface antigens. Immunogenetics 18, 599–615 (1983).
Article CAS PubMed Google Scholar
Testi, R. & Lanier, L. L. Functional expression of CD28 on T cell antigen receptor γ/δ-bearing T lymphocytes. Eur. J. Immunol. 19, 185–188 (1989).
Article CAS PubMed Google Scholar
Kozbor, D., Moretta, A., Messner, H. A., Moretta, L. & Croce, C. M. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J. Immunol. 138, 4128–4132 (1987).
Article CAS PubMed Google Scholar
Hara, T., Fu, S. M. & Hansen, J. A. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161, 1513–1524 (1985).
Article CAS PubMed Google Scholar
Moretta, A., Pantaleo, G., Lopez-Botet, M. & Moretta, L. Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J. Exp. Med. 162, 823–838 (1985).
Article CAS PubMed Google Scholar
Martin, P. J. et al. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J. Immunol. 136, 3282–3287 (1986).
Article CAS PubMed Google Scholar
Weiss, A., Manger, B. & Imboden, J. Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J. Immunol. 137, 819–825 (1986).
Article CAS PubMed Google Scholar
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7, 4472–4481 (1987).
CAS PubMed PubMed Central Google Scholar
Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G. & Thompson, C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339–343 (1989).
Azuma, M. et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76–79 (1993).
Article CAS PubMed Google Scholar
Freedman, A. S., Freeman, G., Horowitz, J. C., Daley, J. & Nadler, L. M. B7, a B-cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139, 3260–3267 (1987).
Article CAS PubMed Google Scholar
Freeman, G. J. et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909–911 (1993).
Article CAS PubMed Google Scholar
Freeman, G. J. et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907–909 (1993).
Article CAS PubMed Google Scholar
Thompson, C. B. et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86, 1333–1337 (1989).
Article CAS PubMed PubMed Central Google Scholar
Bretscher, P. & Cohn, M. A theory of self-nonself discrimination. Science 169, 1042–1049 (1970).
Article CAS PubMed Google Scholar
Brunet, J. F. et al. A new member of the immunoglobulin superfamily-CTLA-4. Nature 328, 267–270 (1987).
Article CAS PubMed Google Scholar
Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
留言 (0)